Growing company focused on the production and sale of menstrual and incontinence supplies

Basic information

The subject of sale is a 100% share in a company focused on development, production and sale of hygiene products for men and women. This is a company that has developed its own original product, secured its production and successfully sells it under its own brand, protected by a trademark in the Czech Republic and Europe.

The products use cutting-edge design and new technologies and provide high functionality, comfort and discretion for users. The products correspond to current sustainability trends and save costs for healthcare systems and end customers. The company stands out for its innovative product development, high quality workmanship and a strong focus on ecology and reusability. The product brand is already well-known in its target group and awareness of it is growing rapidly.

The production itself takes place in the Czech Republic and abroad, which allows us to maintain competitive prices while maintaining high quality. The production costs themselves are very low.

This year, the company’s owners reached an important milestone – the company’s products were approved as a certified medical device by the SÚKL institution (class I according to MDR), bringing significant growth potential for both domestic and international markets. The process of obtaining certification lasted almost a year, with the materials successfully laboratory tested in an accredited laboratory according to the ČSN EN ISO 10993-23 standard. This step by the company opens the door to contracts with health insurance companies, pharmacies and B2B distribution, not only on the Czech market, but also abroad. The company’s current goal is to be part of the reimbursement system for medical devices prescribed on a voucher and covered from public health insurance as soon as possible.

The company’s sales are currently conducted through its own sophisticated e-shop, in which considerable funds have been invested. The initial investment in the project in 2020 to 2022 was approximately 8 million CZK. The marketing strategy has already been set and tested, using mainly social networks and affiliate marketing. Since the beginning of 2024, sales have been expanding to foreign markets in SK, PL and HU, the company also uses sales through marketplaces such as Alza or Allegro.

The company’s target group for menstrual underwear is women aged 12 to 50, clients for incontinence products are men and women aged 12 to 80+. The advantage is a stable sales rate, which is not subject to seasonal fluctuations, and thanks to this, the company’s employment capacity and production are better managed and planned. The company’s business is not subject to crisis periods such as the Covid pandemic or the crisis associated with war. The market in which the company operates is very likely to grow dynamically in the coming years for objective reasons.

The company’s potential is particularly large in the area of ​​incontinence. It is estimated that up to 10-15% of the population suffers from incontinence, with the incidence increasing significantly with age, which represents a broad and stable target group. Incontinence devices declared as medical devices are subject to strict regulation – in particular the obligation to have a valid CE certification according to the MDR. This significantly narrows competition and creates a market barrier that most new brands are unable to overcome. Thanks to this combination of high demand and low competition, the incontinence segment represents an extremely attractive opportunity for growth and expansion. The products are already localized for several markets (including DE, PL, SK, HU) and the certification offers the possibility of rapid expansion into EU markets, where demand for ecological and certified solutions is growing.

The company currently has an average of 3 employees. The owner is mainly involved in strategic management in the company, and this role takes up about 25 hours/week. The owner is selling the company for personal reasons, but is willing to stay in the company for a limited period (about 1 year) after the sale and take on the position of consultant/manager, with the aim of a smooth transfer of the company.

The price includes inventories with a cost value of 7.2 million CZK, these are current goods in their entirety. Such a high value of inventory, which is included in the acquisition price, significantly reduces the acquisition risk for the investor.

This is a unique opportunity to invest in an innovative and agile manufacturer with a unique, certified product in the medical device segment. An ideal opportunity for a strategic partner operating in the medical product range, e-commerce or retail. Suitable for an entity with sufficient financial capacity to scale production and expand export activities. Particularly attractive for companies with experience in B2B sales or building business networks. Thanks to the already established product and brand, the project is ideally scalable.existing distribution network and suitable for rapid expansion into European markets.

More information